# Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS)

> **NCT00638248** · PHASE1,PHASE2 · COMPLETED · sponsor: **PAION Deutschland GmbH** · enrollment: 38 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Desmoteplase
- **DRUG:** Desmoteplase
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00638248
- **Lead sponsor:** PAION Deutschland GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2004-10
- **Final completion:** 2004-10
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2008-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00638248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00638248, "Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00638248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*